Home - Products - Others - Other Targets - 2-Pyrimidinamine, 4-(5-bromo-1H-indol-3-yl)-

2-Pyrimidinamine, 4-(5-bromo-1H-indol-3-yl)-

CAS No. 213473-00-8

2-Pyrimidinamine, 4-(5-bromo-1H-indol-3-yl)-( Meridianin C )

Catalog No. M29544 CAS No. 213473-00-8

2-Pyrimidinamine, 4-(5-bromo-1H-indol-3-yl)- is a marine derived natural products found in Aplidium meridianum.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 264 In Stock
5MG 402 In Stock
10MG 593 In Stock
25MG 888 In Stock
50MG 1242 In Stock
100MG 1701 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    2-Pyrimidinamine, 4-(5-bromo-1H-indol-3-yl)-
  • Note
    Research use only, not for human use.
  • Brief Description
    2-Pyrimidinamine, 4-(5-bromo-1H-indol-3-yl)- is a marine derived natural products found in Aplidium meridianum.
  • Description
    2-Pyrimidinamine, 4-(5-bromo-1H-indol-3-yl)- is a marine derived natural products found in Aplidium meridianum.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Meridianin C
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    213473-00-8
  • Formula Weight
    289.13
  • Molecular Formula
    C12H9BrN4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    BrC=1C=CC=2NC=C(C=3N=C(N=CC3)N)C2C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Sylvestroside I

    Sylvestroside I may have analgesic effect.

  • NU 9056

    NU 9056 is an effective and selective inhibitor of KAT5 histone acetyltransferase with an IC50 of 2 μM. NU 9056 blocks DNA damage response and inhibits protein acetylation in prostate cancer cell lines.

  • Apraglutide TFA (129...

    Apraglutide TFA (FE 203799 TFA), a synthetic 33-amino-acid peptide and a long-acting GLP-2 analogue, enhances adaptation and linear intestinal growth in a neonatal piglet model of short bowel syndrome with total resection of the ileum.